Navigation Links
Inverness Medical Innovations Announces Third Quarter 2008 Results
Date:10/29/2008

stock options and warrants. Potential

dilutive shares consisting of 2,868,000 common stock equivalent

shares from the potential conversion of convertible debt securities

for the three months ended September 30, 2007 were not used in the

calculation of diluted net income per common share, or on an

adjusted cash basis, because inclusion thereof would be

antidilutive.

Inverness Medical Innovations, Inc. and Subsidiaries

Condensed Consolidated Statements of Operations and

Reconciliation to Non-GAAP Adjusted Cash Basis Amounts

(in $000s, except per share amounts)

Nine Months Ended September 30, 2008

Non-GAAP

Non-GAAP Adjusted Cash

GAAP Adjustments Basis(a)

Net revenue $1,212,160 $- $1,212,160

Cost of revenue 597,520 (53,560)(b)( c ) 543,960

(d)(e)

Gross profit 614,640 53,560 668,200

Gross margin 51% 55%

Operating expenses:

Research and development 86,426 (13,080)(b)( c )(d) 73,346

Purchase of in-process

research and development - -

Selling, general and

administrative 496,687 (142,286)(b)( c )(d) 354,401

Total operating expenses 583,113 (155,366) 427,747

Operating income

(loss) 31,527 208,926 240,453

Interest and other income

(expense), net (84,151) 8,615( c )(h) (7
'/>"/>

SOURCE Inverness Medical Innovations, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related biology technology :

1. Inverness Medical Innovations Schedules Conference Call for 10:00 a.m. ET October 29, 2008 to Discuss Third Quarter 2008 Results
2. Inverness Medical Innovations to Present at the UBS Global Life Sciences Conference on September 22, 2008
3. Inverness Medical Innovations to Attend the Goldman Sachs Diagnostics Conference on September 18, 2008
4. Inverness Medical Innovations Declares Dividend on its Series B Convertible Perpetual Preferred Stock
5. Inverness Medical Innovations to Present at the Morgan Stanley Global Healthcare Unplugged Conference on September 9, 2008
6. Inverness Medical Innovations Features Innovative TB Diagnostic - Clearview(R) TB ELISA at AIDS 2008
7. Inverness Medical Innovations to Present at Canaccord Adams 28th Annual Growth Conference on August 12, 2008
8. Inverness Medical Innovations Announces Second Quarter 2008 Results
9. Inverness Medical Innovations to Present at Jefferies 2nd Annual Healthcare Conference held on June 25, 2008
10. Inverness Medical Innovations to Present at 7th Annual Needham & Company, LLC Biotechnology & Medical Technology Conference on June 12, 2008
11. Inverness Medical Innovations to Present at FBR Capital Markets 12th Annual Spring Investor Conference on May 28, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... July 30, 2014 Sales Horizons, a ... of blended sales training programs for companies engaged in ... programs used by thousands of salespeople over 25 years ... training program can be customized to address the unique ... blended sales training program consists of two ...
(Date:7/30/2014)... 2014 With the accelerated aging ... health expenditure as well as the improved medical ... diagnostic reagent industry has been developing quickly, especially ... 2013, Chinese in vitro diagnostics market size reached ... in vitro diagnostic reagents. , Read complete ...
(Date:7/30/2014)... Wellesley, MA (PRWEB) July 30, 2014 ... report, Global Markets for Enzymes in Industrial Applications ... to reach to nearly $7.1 billion by 2018, registering ... Maximum growth is estimated to be recorded in the ... the forecast period. , Enzyme technology has influenced almost ...
(Date:7/30/2014)... Yuma Regional Cancer Center Officially Opens ... comprehensive cancer care to Yuma, Arizona. , The ... has officially opened. A Mayo Clinic Care Network ... as open, semi-private and private infusion rooms, oncology ... Center, hematology, rehabilitation center, a pain management program ...
Breaking Biology Technology:Sales Horizons Launches New Blended Sales Training Programs to Companies Engaged in Complex B2B Sales 2Sales Horizons Launches New Blended Sales Training Programs to Companies Engaged in Complex B2B Sales 3China Diagnostic Reagent Industry Report, 2013-2016 | Researchmoz 2China Diagnostic Reagent Industry Report, 2013-2016 | Researchmoz 3Global Market for Industrial Enzymes to Reach Nearly $7.1 Billion by 2018; Detergent Enzyme Market to Record Maximum Growth 2Global Market for Industrial Enzymes to Reach Nearly $7.1 Billion by 2018; Detergent Enzyme Market to Record Maximum Growth 3Sate-of-the-Art Yuma Regional Cancer Center Officially Opens 2
... Md., Feb. 8, 2011 Spherix Incorporated (Nasdaq: ... in diabetes, metabolic syndrome and atherosclerosis; and providers of ... and pharmaceutical companies, today announced that its President, Dr. ... BIO CEO & Investor Conference to be held in ...
... Md., Feb. 8, 2011 United Therapeutics Corporation (Nasdaq: ... release its fourth quarter and annual 2010 financial results ... United Therapeutics will host a half-hour teleconference on ...  The teleconference is accessible by dialing 1-877-351-5881, with international ...
... 2011 -- A low cost, nanometer-sized drug to treat ... been developed by a group of scientists from the Hebrew ... U.S. and Japan. Diabetes is a rapidly growing ... population. Poor blood circulation arising from diabetes often results in ...
Cached Biology Technology:Spherix to Present at the 13th Annual BIO CEO & Investor Conference 2Spherix to Present at the 13th Annual BIO CEO & Investor Conference 3
(Date:7/30/2014)... from the University of Helsinki and the Universitat Autnoma ... mice morphological changes which have taken millions of years ... embryonic development of mice teeth, induced in the laboratory, ... to those observed in the fossil registry of rodent ... , To modify the development of their teeth, ...
(Date:7/30/2014)... dominance in female baboons suggests that the route to a ... to have lots of supportive sisters. , A female baboon,s ... by the rank of her mother - the higher the ... this reason, dominance rank in female baboons is thought to ... guaranteed a good spot in the pecking order, whereas females ...
(Date:7/30/2014)... HIV infection could be as simple as inserting a ... University of Washington bioengineers have discovered a potentially faster ... from contracting HIV. Their method spins the drug into ... moisture, releasing higher doses of the drug than possible ... , "This could offer women a potentially more effective, ...
Breaking Biology News(10 mins):Scientists reproduce evolutionary changes by manipulating embryonic development of mice 2Supportive moms and sisters boost female baboon's rank 2Supportive moms and sisters boost female baboon's rank 3Dissolvable fabric loaded with medicine might offer faster protection against HIV 2Dissolvable fabric loaded with medicine might offer faster protection against HIV 3
... wisdom teeth are not much more than an annoyance that ... in the September 17 Journal of Biological Chemistry ... for the creation of stem cells; thus, everyone might be ... he or she ever need some. Groundbreaking research back ...
... Mount Sinai School of Medicine have found that bisphenol A ... is detectable in the saliva after placement in children,s mouths. ... associated with changes in behavior, prostate and urinary tract development, ... the current issue of Pediatrics . Reins containing ...
... of Scots Pine trees, scientists have shown that the iconic ... the ancestors that colonised Britain after the end of the ... future populations, according to new results published in the journal ... an international team from the Centre for Ecology & Hydrology, ...
Cached Biology News:A smart use for wisdom teeth: Making stem cells 2Mount Sinai researchers analyze impact of chemical BPA in dental sealants used in children 2Scots Pine shows its continental roots 2
... is essential for hunting and analyzing ... such as EST sequencing projects, microarrays, ... kit is developed for normalization of ... intended for directional cloning. While most ...
Polyclonal Antibody to HADHB...
A431 cells Source: Cell Lysate Form: Ready to Use Application: Western Blotting Control...
PC12 (rat phaeochromocytoma) cells Source: Cell Lysate Form: Ready to Use Application: Western Blotting Control...
Biology Products: